08.15.08
Azopharma Product Development Group plans to expand its clinical research management services through its newly formed company, Acromon Clinical Research Organization. This company adds to the services provided by the human clinical dosing unit, AvivoClin, and the bioanalytical services unit, ADMEQuant.
The new organization will provide clinical management services for human clinical trials. Acromon will operate independently from other Azopharma companies in order to design and monitor trials in an unbiased manner, whether the study is performed at the AvivoClin site or another clinical facility. The staff will provide the designing, monitoring and technical writing aspects of clinical studies with a focus on regulatory compliance.
Phil Meeks, Azopharma’s chief executive officer, said, “This expansion will help us to meet the growing needs of the clinical design and execution market which has seen steady growth for the past few years. This expansion will also help us more fully serve our clients’ needs for total product development.”
Acromon’s services include clinical study development, protocol design, clinical monitoring, data management, biostatistical analysis and reporting, and final clinical study report writing.
The new organization will provide clinical management services for human clinical trials. Acromon will operate independently from other Azopharma companies in order to design and monitor trials in an unbiased manner, whether the study is performed at the AvivoClin site or another clinical facility. The staff will provide the designing, monitoring and technical writing aspects of clinical studies with a focus on regulatory compliance.
Phil Meeks, Azopharma’s chief executive officer, said, “This expansion will help us to meet the growing needs of the clinical design and execution market which has seen steady growth for the past few years. This expansion will also help us more fully serve our clients’ needs for total product development.”
Acromon’s services include clinical study development, protocol design, clinical monitoring, data management, biostatistical analysis and reporting, and final clinical study report writing.